氨酸在患有脑膜上高心率心跳动的患者中的电生理效应
K A Glatter1, J Cheng, P Dorostkar
1Cardiovascular Research Institute and Section of Cardiac Electrophysiology, University of California-San Francisco, CA, USA.
Circulation
|March 2, 1999
概括
亚丁氨酸 (Adenosine) 是一种
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
背景情况:
- 腺素的电生理学 (EP) 效应与患有脑上脑膜上心动脉 (SVT) 患者的心动脉动机制相关.
研究的目的:
- 评估腺在区分SVT机制中的实用性.
- 为了识别与不同类型的心力衰竭相关的特定EP对腺的反应.
主要方法:
- 在EP研究期间,阿诺辛被给予了229名患有各种SVT的患者.
- 观察并记录了心律,间隔 (心房,心房,心房间) 和心跳骤停的变化.
- 在不同的SVT亚型中比较腺素反应:AVRT,AVNRT,PJRT,AT和IST.
主要成果:
- 腺氨酸在AVRT和AVNRT的AV节点表现出类似的高心跳终止率.
- 在AVRT中观察到心室内 (VA) 间隔的增加,但不是典型的AVNRT.
- 主要在AT和IST患者中观察到AV阻塞.
- 与AVNRT相比,AVRT,PJRT和AT的心房动发生率更高.
- IST患者的心房周期长度增加,但没有显著的激活序列变化.
结论:
- 氨酸的EP反应在确定AT位置或特定的SVT机制方面具有有限的价值.
- 在抑制之前的AV阻塞和缩短的心房周期长度表明AT.
- 在AVRT,PJRT或AT中,腺素后心房动更为频繁.
- IST患者在腺后表现出延长的周期长度和稳定的心房激活.
相关概念视频
Muscle Stimulation Frequency
The contraction strength of muscles is regulated by motor neurons, which modulate the frequency of action potentials dispatched to the motor units based on the body's requirements. This process of varying the muscle stimulation frequency allows muscles to contract with a force that is precisely tailored to the needs of the moment, whether lifting a feather or a heavy box.
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


